REFERENCES
- Grant RM, Lama JR, Anderson PL, . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men (MSM). N Engl J Med 2010;363:2587–99.
- Thigpen MC, Kebaabetswe PM, Paxton LA, . Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012;367:423–34.
- Van Damme L, Corneli A, Ahmed K, . Preexposure prophylaxis for HIV infection among African women. N Engl J Med 2012;367:411–22.
- Baeten JM, Donell D, Ndase P, . Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012;367:399–410.
- Clinical trial of antiretroviral-based HIV prevention strategies for women now under way.NIH News. U.S. Department of Health and Human Services – National Institutes of Health 2009. Accessed 24 July 2012 from: “http://www.niaid.nih.gov/news/newsreleases/2009/Pages/VOICE.aspx”
- MTN statement on decision to discontinue use of tenofovir gel in VOICE, a major HIV prevention study in women.Microbicide Trials Network (MTN) 2011. Accessed 24 July 2012 from: http://www.mtnstopshiv.org/node/3909
- Kalichman SC, Eaton L, Cain D, . HIV treatment beliefs and sexual transmission risk behaviors among HIV positive men and women. J Behav Med 2006;29: 401–10.
- Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA 2004;292:224–36.
- Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis 2010;50(Suppl. 3):S85–S95.
- Cohen MS, Baden LR. Preexposure prophylaxis for HIV – Where do we go from here? N Engl J Med 2012; 367:459–61.
- Lewden C, Salmon D, Morlat P, . Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005;34:121–30.
- Mills EJ, Bärnighausen T, Negin J. HIV and aging – Preparing for the challenges ahead. N Engl J Med 2012;366:1270–3.
- Cohen MS, Chen YQ, McCauley M, . Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med 2011;365:493–505.
- Paltiel AD, Freedberg KA, Scott CA, . HIV pre-exposure prophylaxis (PrEP) in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clin Infect Dis 2009;48:806–15.
- Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR 2011;60:65–8.
- Grady D. F.D.A. advisory panel backs preventive use of H.I.V. drug. New York Times 10 May 2012:D5.
- Steinbrook R. Imposing personal responsibility for health. N Engl J Med 2006;355:753–6.
- Golan O. The right to treatment for self-inflicted conditions. J Med Ethics 2010;36:683–6.
- Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 2004;291:1238–45.
- Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Correction: actual causes of death in the United States, 2000. JAMA 2005;293:293–4.
- Pomerleau J, Pederson LL, Ostbye T, . Health behaviours and socio-economic status in Ontario, Canada. Eur J Epidemiol 1997;13:613–22.
- Najman JM, Toloo G, Siskind V. Socioeconomic disadvantage and changes in health risk behaviours in Australia: 1989-90 to 2001. Bull World Health Organ 2006;84:976–84.
- Vereecken CA, Maes L, De Bacquer D. The influence of parental occupation and the pupils’ educational level on lifestyle behaviors among adolescents in Belgium. J Adolesc Health 2004;34:330–8.
- Mullie P, Clarys P, Hulens M, Vansant G. Dietary patterns and socioeconomic position. Eur J Clin Nutr 2010;64:231–8.
- Rey-López JP, Vicente-Rodríguez G, Répásy J, . Food and drink intake during television viewing in adolescents: the Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) study. Public Health Nutr 2011;14:1563–9.
- Lancement de l'essai ANRS Ipergay. Le 1er essai de prévention pré-exposition du VIH pour les gays en France. Agence nationale de recherches sur le sida et les hépatites virales (ANRS) 2012. Accessed 24 July 2012 from: http://www.anrs.fr/VIH-SIDA/Clinique/Actualites